secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001404644-25-000049
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurogene posts updated corporate presentation; no material new info disclosed
------------------------------------------------------------------------------

- Filing reports only that an updated corporate presentation was posted on June 9, 2025.
- No financial results, guidance, or operational milestones provided in the filing body.
- Exhibit 99.1 referenced but its full content not available in this summary; limited to a header only.
- Investors should refer to the presentation directly for any potential updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000140464425000049/0001404644-25-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000140464425000049/ngne-20250609.htm
  HTML page:      https://secwatch.observer/filing/0001404644-25-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer